Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.3M | $6.8M | $14.5M | $12.4M | $27.9M | $209.7M | $222.0M | $980.6M |
| Cost of revenue | $0 | $0 | $2.1M | $2.0M | $3.3M | $22.0M | $30.5M | $29.1M |
| Gross profit | $6.3M | $6.8M | $12.4M | $10.5M | $24.6M | $187.7M | $191.4M | $951.6M |
| Gross margin | 100.0% | 100.0% | 85.6% | 84.2% | 88.1% | 89.5% | 86.2% | 97.0% |
| R&D | $118.8M | $249.6M | $463.9M | $564.6M | $766.5M | $743.1M | $707.0M | $947.2M |
| Operating income | −$130.7M | −$332.5M | −$582.7M | −$663.9M | −$869.8M | −$849.8M | −$872.6M | −$369.7M |
| EBITDA | −$49.7M | −$318.4M | −$596.3M | −$667.5M | −$916.0M | −$836.0M | −$743.6M | −$237.6M |
| Net income | −$118.5M | −$345.3M | −$1.48B | −$677.6M | −$782.4M | −$882.9M | −$925.6M | −$405.4M |
| Net margin | -1872.9% | -5072.8% | -10202.7% | -5442.6% | -2803.4% | -421.0% | -417.0% | -41.3% |
| EPS (diluted) | -2.29 | -6.67 | -28.01 | -12.56 | -12.28 | -13.40 | -13.12 | -1.34 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds AAPGV.
No tracked institution reports a position in AAPGV as of their last filing.
No one on the platform has traded AAPGV yet.
| $123M |
| — |
| GRAYGraybug Vision, Inc. | $5.50 | -10.80% | $121M | — |
| KNTEKinnate Biopharma Inc. | $2.65 | -0.38% | $125M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.